pharm 1 liner- heme/onco Flashcards
Antineoplastic pyrimidine analog that inhibits DNA polymerase
cytarabine
Drug used concurrently with antineoplastics to reduce renal precipitation of urates
allopurinol
Agent used for megaloblastic anemia (but does not reverse neurologic symptoms) and decrease neural tube defects during pregnancy
folic acid
Three antineoplastic purine analogs that inhibit purine synthesis
azathioprine, 6-mercaptopurine, 6-thioguanine
Serious side effect of cyclophosphamide and ifosfamide due to generation of acrolein
hemorrhagic cystitis
Ribonucleotide reductase inhibitor with S phase cell cycle selectivity that is used for management of sickle cell anemia
hydroxyurea
Humanized monoclonal antibody against CD52 that is used to treat chronic lymphocytic leukemia
alemtuzumab
Agent that is used to bind acrolein and prevent drug-induced hemorrhagic cystitis
mesna
Neurotoxicity (areflexia, peripheral neuritis) is commonly associated with
Microtubule inhibitors : vinca alkaloids (e.g., vincristine, vinblastine), taxanes (e.g., paclitaxel)
Alkylating agent that has greater activity against myeloid cells than lymphoid cells; serious side effects include myelosuppression and pulmonary fibrosis
busulfan
Agent used for megaloblastic anemia with neurological deficits
vitamin B12
Inhibits microtubule formation by binding to β-tubulin; dose-limiting side effect is neurotoxicity
vincristine
Platinum-derivatives that form DNA intrastrand cross-links; causes dose-limiting nephrotoxicity, ototoxicity, and neurotoxicity
cisplatin, carboplatin
Two antineoplastics that inhibit topoisomerase I
Irinotecan, topotecan
Agent used for anemias (especially with renal failure)
erythropoietin
Inhibits BRAF kinase in melanomas with BRAF V600E mutation
vemurafenib
Antineoplastic can be used as intravesical treatment for superficial bladder cancer and associated with hemolytic-uremic syndrome
mitomycin
DNA intercalating agent with minimal myelosuppression that induces formation of free radicals; dose-limiting side effects include pulmonary fibrosis and mucocutaneous reactions
bleomycin
Anthracycline-induced cardiotoxicity (dilated cardiomyopathy) is caused by
increased production of free radicals within myocardium
Agent used for hypochromic microcytic anemias
ferrous sulfate
Antineoplastic folic acid analog that inhibits dihydrofolate reductase
methotrexate
Irinotecan use is limited because of one severe adverse effect
Gastrointestinal toxicity (life-threatening diarrhea)
Two most commonly used glucocorticoids for cancer due to their lymphotoxic effects; may cause Cushing-like symptoms
prednisone, prednisolone
Agent that is used to detoxify reactive metabolites and savenge free radical and prevent drug-induced nephrotoxicity (Fanconi syndrome, acute tubular necrosis)
amifostine
DNA intercalating agent useful for treatment of solid tumors in children
dactinomycin (actinomycin D)
Enzyme activates purine analogs
hypoxanthine-guanine phosphoribosyltransferase (HGPRT)
Alkylating drugs cause disulfiram-like reaction to alcohol
decarbonize, procarbazine
Serious side effect associated with cytarabine
pancytopenia
Recombinant human monoclonal antibody against human epidermal growth factor-2 (HER2) receptor; useful for breast cancer cells that overexpress HER2
trastuzumab
Hyperstabilizes microtubule polymer and prevents microtubule breakdown
paclitaxel, -taxels
Two anthracyclines that chelate DNA, form free radicals, and cause dose-limiting cardiotoxicity
duanorubicin, doxorubicin
Iron-chelator that is used to protect against anthracycline-induced cardio-toxicity
dexrazoxane
Two antineoplastics that require dose-reduction in patients who are taking allopurinol
azathioprine, 6-mercaptopurine
Antineoplastic with G2 phase cell cycle selectivity
bleomycin
Antineoplastics that inhibit topoisomerase II
Etoposide, teniposide, Anthracyclines, Amsacrine
Gonadotropin-releasing hormone agonist that can be used to inhibit luteinizing hormone secretion and testosterone production in men with advanced prostate cancer when administered continously
leoprolide
Nitrosureas that spontaneously form active intermediates that cross-link DNA; can cross blood-brain-barrier and is indicated for brain tumors
carmustine, -mustines
Agent used for pernicious anemia
cyanocobalamin (vitamin B12)
Recombinant human monoclonal antibody against vascular endothelial growth factor (VEGF)
bevacizumab
Inhibits microtubule formation by binding to β-tubulin; dose-limiting side effect is bone marrow suppression
vinblastine
Azathioprine is a prodrug for
6-mercaptopurine
Partial or complete deficiency of an enzyme can increase the toxicity of 5-FU
dihydropyrimidine dehydrogenase (pharmacogenetic syndrome)
Antineoplastic pyrimidine analog that inhibits thymidylate synthetase
5-fluorouracil (5-FU)
Inhibits BCR-ABL tyrosine kinase expressed by the Philadelphia chromosome in chronic myeloid leukemia
imatinib
agent used for neutropenia associated with cancer chemotherapy and bone marrow trnasplantation
filgrastim (granulocyte colony-stumating factor) and sargramostim (granulocyte-macrophage colony stimulating factor)
Vinca alkaloids cause excessive free water retention and euvolemic hyponatremia
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
Two prodrugs, that after liver bioactivation, bind to N7 nitrogen of guanine and cross-link DNA
cyclophosphamide, ifosfamide
Chimeric monoclonal antibody against CD20 antigen found on non-Hodgkin lymphomas and normal B lymphocytes
rituximab
Increase activity of cytotoxic cells and indicated for hairy cell leukemia
interferon alpha-2b